Matches in SemOpenAlex for { <https://semopenalex.org/work/W44157079> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W44157079 endingPage "4" @default.
- W44157079 startingPage "790" @default.
- W44157079 abstract "Topical treatments, such as adapalene and benzoyl peroxide (BPO), are popular in mild-to-moderate acne vulgaris. This study aimed to compare the efficacy, safety and tolerability of adapalene and BPO in mild acne vulgaris. In this single-center, randomized, double-blind, clinical trial, 60 patients with mild acne vulgaris received either topical adapalene 0.1% gel or topical BPO 2.5% gel on their face once daily for two months. The changes of acne lesion count (efficacy), any adverse effect (safety), and the patients' overall satisfaction (tolerability) were compared after 3 months of follow-up. In both groups the mean number of noninflammatory, inflammatory and total lesions decreased significantly from baseline (10.77±5.54, 9.73±5.09, and 20.50±7.54, respectively in adapalene group; 11.50±5.92, 8.43±5.45, and 19.93±9.01, respectively in BPO group) to the third month (1.70±1.68, 0.33±0.66, and 0.50±0.78, respectively in adapalene group; 4.23±4.14, 0.33±0.71, and 4.13±4.44, respectively in BPO group; P<0.001 for all), posttreatment. Although the mean number of inflammatory lesions was significantly lower in BPO receivers only at first month (P =0.001), the mean number of noninflammatory and total lesions was significantly lower in adapalene group at second (P = 0.04 and 0.03, respectively) and third (P =0.02 and <0.001, respectively) months, posttreatment. The adverse events were minimal and self-limited (26.7% in adapalene group, 20% in BPO group, p=0.54). The patients' overall satisfaction was good to excellent in 93.3% of adapalene receivers vs. 73.3% in BPO group (P=0.08). Both topical adapalene 0.1% and BPO 2.5% gels seem safe and effective in mild acne vulgaris, with a marginal tendency toward the former." @default.
- W44157079 created "2016-06-24" @default.
- W44157079 creator A5039341619 @default.
- W44157079 creator A5090385815 @default.
- W44157079 date "2013-07-01" @default.
- W44157079 modified "2023-09-27" @default.
- W44157079 title "The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial." @default.
- W44157079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24002152" @default.
- W44157079 hasPublicationYear "2013" @default.
- W44157079 type Work @default.
- W44157079 sameAs 44157079 @default.
- W44157079 citedByCount "8" @default.
- W44157079 countsByYear W441570792015 @default.
- W44157079 countsByYear W441570792016 @default.
- W44157079 countsByYear W441570792017 @default.
- W44157079 countsByYear W441570792018 @default.
- W44157079 countsByYear W441570792020 @default.
- W44157079 crossrefType "journal-article" @default.
- W44157079 hasAuthorship W44157079A5039341619 @default.
- W44157079 hasAuthorship W44157079A5090385815 @default.
- W44157079 hasConcept C126322002 @default.
- W44157079 hasConcept C16005928 @default.
- W44157079 hasConcept C168563851 @default.
- W44157079 hasConcept C178790620 @default.
- W44157079 hasConcept C185592680 @default.
- W44157079 hasConcept C197934379 @default.
- W44157079 hasConcept C2777140388 @default.
- W44157079 hasConcept C2777673923 @default.
- W44157079 hasConcept C2778375690 @default.
- W44157079 hasConcept C2778885487 @default.
- W44157079 hasConcept C44228677 @default.
- W44157079 hasConcept C521977710 @default.
- W44157079 hasConcept C535046627 @default.
- W44157079 hasConcept C71924100 @default.
- W44157079 hasConceptScore W44157079C126322002 @default.
- W44157079 hasConceptScore W44157079C16005928 @default.
- W44157079 hasConceptScore W44157079C168563851 @default.
- W44157079 hasConceptScore W44157079C178790620 @default.
- W44157079 hasConceptScore W44157079C185592680 @default.
- W44157079 hasConceptScore W44157079C197934379 @default.
- W44157079 hasConceptScore W44157079C2777140388 @default.
- W44157079 hasConceptScore W44157079C2777673923 @default.
- W44157079 hasConceptScore W44157079C2778375690 @default.
- W44157079 hasConceptScore W44157079C2778885487 @default.
- W44157079 hasConceptScore W44157079C44228677 @default.
- W44157079 hasConceptScore W44157079C521977710 @default.
- W44157079 hasConceptScore W44157079C535046627 @default.
- W44157079 hasConceptScore W44157079C71924100 @default.
- W44157079 hasIssue "7" @default.
- W44157079 hasLocation W441570791 @default.
- W44157079 hasOpenAccess W44157079 @default.
- W44157079 hasPrimaryLocation W441570791 @default.
- W44157079 hasRelatedWork W1730169 @default.
- W44157079 hasRelatedWork W2103367276 @default.
- W44157079 hasRelatedWork W2138211925 @default.
- W44157079 hasRelatedWork W2239502113 @default.
- W44157079 hasRelatedWork W2315795079 @default.
- W44157079 hasRelatedWork W3132268980 @default.
- W44157079 hasRelatedWork W4250691982 @default.
- W44157079 hasRelatedWork W4254332142 @default.
- W44157079 hasRelatedWork W49852758 @default.
- W44157079 hasRelatedWork W55905745 @default.
- W44157079 hasVolume "12" @default.
- W44157079 isParatext "false" @default.
- W44157079 isRetracted "false" @default.
- W44157079 magId "44157079" @default.
- W44157079 workType "article" @default.